GB2129792A - Sulpiride derived compound - Google Patents
Sulpiride derived compound Download PDFInfo
- Publication number
- GB2129792A GB2129792A GB08326619A GB8326619A GB2129792A GB 2129792 A GB2129792 A GB 2129792A GB 08326619 A GB08326619 A GB 08326619A GB 8326619 A GB8326619 A GB 8326619A GB 2129792 A GB2129792 A GB 2129792A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulpiride
- indomethazine
- new derivative
- methyl
- methoxi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/26—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an acyl radical attached to the ring nitrogen atom
- C07D209/28—1-(4-Chlorobenzoyl)-2-methyl-indolyl-3-acetic acid, substituted in position 5 by an oxygen or nitrogen atom; Esters thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
A new compound derived from the sulpiride, having the formula <IMAGE> and named 1-(p-chlorobenzoyl-2-methyl-5-methoxy-3-indolyl-acetate of N-(1-ethyl-2-pirrolidinyl)methyl-2-methoxy-5-sulfamoyl benzamide with antiinflammatory properties and a process for the preparation of said compound consisting in reacting the indomethazine or an indomethazine organic or inorganic salt with sulpiride or a sulpiride organic or inorganic salt in water, water with a hydrosoluble organic solvent, an organic solvent or a mixture of organic solvents at a temperature between 20 and 80 DEG C.
Description
SPECIFICATION
Sulpiride derived compound
This invention refers to a new compound derived from the sulpiride, wich developed formula is as follows:
This compound named 1 -(p-chlorobenzoyl)-2-methyl-5-methoxi-3-indolylacetate of N-(1 -ethyl-2- pirrolidinyl) methyl-2-methoxi-5-sulfamoylbenzamide appears as a yellow crystalline solid melting at 156-157 C and being formed by the link of an indomethazine molecule with a sulpiride molecule, consequently retaining the remarkable therapeutical properties of the indomethazine strengthened by the sulpiride molecularly linked thereto. This combination provides the new product with the maintenance of the indomethazine antiinflammatory property, while helping its bioavailability and reducing its gastroperturbing effects.
The invention further refers to a process for obtaining the compound named 1-(p-chlornbenzoyl)2-methyl- 5-methoxi-3-indolylacetate of N-(1 -ethyl-2-pirrolidinyl) methyl-2-methoxi-5-sulfamoylbenzamide. This process is of easy fulfillment, allows the use of current solvents and results in a high purity product.
According to the process of the invention, indomethazine or its salts are reacted in molecular ratios with sulpiride or its salts. As indomethazine salt can be used a salt of indomethazine with an organic base or a salt of indomethazine with an inorganic base, and as sulpiride salt can be used a salt of sulpiride with an organic acid or a salt of a sulpiride with an inorganic acid.
Reaction media can be chosen between water, water with a hydrosoluble organic solvent and a mixture of organic solvents, keeping said reaction media at a temperature between 20 and 80"C.
Now it follows without making any limitation whatsoever into the scope of the invention, several examples of the preparation of 1-(p-chlorobenzoyl)-2-methyl-5-methoxi-3-indolylacetate of N-(1 -ethyl-2- pirrolidinyl)methyl-2-methoxi-5-sulfamoylbenzamide.
Example 1
40 g indomethazine were suspended by stirring into 250 ml of ethylacetate.
Suspension was heated at 60"C and 34 g. sulpiride were added thereto. Heating and stirring were continued about 15 minutes and it was then quickly cooled at room temperature. It was filtered and washed with ethyl acetate.
The resultant product was recrystallized into 3250 ml isopropanol. About 60 g. yellow crystalline solid (yield 82%) with melting point 156-157 C were obtained.
Example 2
100 g. indomethazine were added to a solution of 30 g. triethylamine into 300 ml. methanol, while stirring at room temperature.
The solution obtained was poured over another solution of 94 g. sulpiride into 280 ml N acetic acid. It was stirried about 15 minutes. The solution obtained was vacuum isopropanol.
About 160 g. yellow crystals with melting point 156-157"C were obtained.
Example 3
50 g. indomethazine were diluted at room temperature into 1400 ml 0.1 N caustic soda.
47 g. sulpiride were separately diluted into 140 ml N acetic acid and the solution diluted with 1000 ml distilled water.
The two solutions were mixed while stirred. The solution obtained was further stirred at room temperature about 15 minutes and then vacuum concentrated. The solid residues obtained were recrystallized with isopropanol. About 78-80 g. yellow crystallized powder with melting point 156-157 C were obtained.
Example 4
A solution of 100 g. (0.28 m.) indomethazine and 30 g. (0.3) triethylamine into 300 ml methanol at a temperature of 40 C was prepared.
Another solution of 100 g. (0.26 m) sulpiride chlorhydrate into 300 ml distilled water at a temperature of 70 C was separately prepared.
Both solutions were filtered and mixed at 700C and the mixture was stirred at this temperature about one hour. The solution was then cooled and left in the refrigerator several hours. The separated solid was filtered and washed with a mixture of methanol/water (1:1).
Finally it was recrystallized into 7.51. isopropanol. 150 g. yellow crystalline solid with melting point 156-157"C (yield 83%) were obtained.
Molecule formula is C34H39CIN408S.
The basic analysis of the substance obtained turned out the following results:
Estimated : C = 58.40, H = 5.62, N = 8.01 Cl = 5.07, S = 4.59
Found : C = 58.34, H = 5.65, N = 8.04 Cl = 5.05, S = 4.50
In the spectrum the following absorption bands would be shown: 3,370cm - 1 ........................................ (2.97 nm) 3,320cm - 1 ........................................ (3.01 nm) 1,650 cm 1 -1 1,610cm-1 ........................................ (6.21nm) nm) 1,230 cm - 1 -1 860cm-1 ........................................ (11.6nm) 825cm-1 ........................................ (12.1 nm)
810cm-1 ........................................ (12.3 nm) 800cm-1 ........................................ (12.nm)
Claims (1)
1. A new derivative of sulpiride named 1-(p-chlorobenzoyl)-2-methyl-5-methoxi-3-indolylacetate of
N-(1 -ethyl-2-pirrnlidinyl)methyl-2-methoxi-5-sulfamoyl-benzamide with the formula:
a product of molecular addition formed by an indomethazine molecule and a sulpiride molecule.
2. A process for obtaining a new derivative of sulpiride named 1-(p-chlorobenzoyl)-2-methyl-5-methoxi- 3-indolylacetate of N-(1-ethyl-2-pirrolidinyl) methyl-2-methoxi-5-sulfamoylbenzamide, characterized in that indomethazine and sulpiride are reacted in a molecular ratio, as much as such substances and in the form of salts thereof, in media chosen between water, water with a hydrosoluble organic solvent, an organic solvent and a mixture of organic solvents, keeping the media at a temperature between 20 and 80"C and the compound formed in the reaction is purified and isolated.
3. A process according to claim 2, characterized in that the indomethazine is used in the form of a salt of indomethazine with an organic base.
4. A process according to claim 2, characterized in that the indomethazine is used in the form of a salt of indomethazine with an inorganic base.
5. A process according to claim 2,3 or 4 characterised in that sulpiride is used in the form of a salt of sulpiride with an organic acid.
6. A process according to claim 2,3 or 4 characterised in that sulpiride is used in the form of a salt of sulpiride with an inorganic acid.
7. A new derivative of sulpiride as claimed in claim 1 and according to Example 1.
8. A new derivative of sulpiride as claimed in claim 1 and according to Example 2.
9. A new derivative of sulpiride as claimed in claim 1 and according to Example 3.
9. A new derivative of sulpiride as claimed in claim 1 and according to Example 4.
11. A process for obtaining a new derivative of sulpiride as claimed in claim 2 and according to Example 1.
12. A process for obtaining a new derivative of sulpiride as claimed in claim 2 and according to Example 2.
13. A process for obtaining a new derivative of sulpiride as claimed in claim 2 and according to Example 3.
14. A process for obtaining a new derivative of sulpiride as claimed in claim 2 and according to Example 4.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES516786A ES516786A0 (en) | 1982-10-08 | 1982-10-08 | PROCEDURE FOR OBTAINING A NEW DERIVATIVE OF THE SULPIRIDE. |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8326619D0 GB8326619D0 (en) | 1983-11-09 |
GB2129792A true GB2129792A (en) | 1984-05-23 |
GB2129792B GB2129792B (en) | 1986-02-12 |
Family
ID=8484830
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08326619A Expired GB2129792B (en) | 1982-10-08 | 1983-10-05 | Sulpiride derived compound |
Country Status (7)
Country | Link |
---|---|
JP (1) | JPS5988463A (en) |
BE (1) | BE897948A (en) |
DE (1) | DE3336762A1 (en) |
ES (1) | ES516786A0 (en) |
FR (1) | FR2534254B1 (en) |
GB (1) | GB2129792B (en) |
PT (1) | PT77463B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003099293A1 (en) * | 2002-05-23 | 2003-12-04 | Danmarks Farmaceutiske Universitet | Pharmacologically active salts |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2093693A (en) * | 1981-02-24 | 1982-09-08 | Ciba Geigy Ag | Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids novel carboxylic acid salts and the production thereof. |
-
1982
- 1982-10-08 ES ES516786A patent/ES516786A0/en active Granted
-
1983
- 1983-09-22 FR FR8315047A patent/FR2534254B1/en not_active Expired
- 1983-10-05 GB GB08326619A patent/GB2129792B/en not_active Expired
- 1983-10-06 PT PT77463A patent/PT77463B/en not_active IP Right Cessation
- 1983-10-06 JP JP58186071A patent/JPS5988463A/en active Pending
- 1983-10-07 BE BE0/211669A patent/BE897948A/en not_active IP Right Cessation
- 1983-10-10 DE DE19833336762 patent/DE3336762A1/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2093693A (en) * | 1981-02-24 | 1982-09-08 | Ciba Geigy Ag | Pharmaceutical preparations for topical application which contain salts of alkanecarboxylic acids novel carboxylic acid salts and the production thereof. |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003099293A1 (en) * | 2002-05-23 | 2003-12-04 | Danmarks Farmaceutiske Universitet | Pharmacologically active salts |
Also Published As
Publication number | Publication date |
---|---|
FR2534254B1 (en) | 1985-07-12 |
ES8407042A1 (en) | 1984-09-01 |
ES516786A0 (en) | 1984-09-01 |
DE3336762A1 (en) | 1984-04-12 |
PT77463A (en) | 1983-11-01 |
GB8326619D0 (en) | 1983-11-09 |
GB2129792B (en) | 1986-02-12 |
BE897948A (en) | 1984-01-30 |
PT77463B (en) | 1986-02-26 |
JPS5988463A (en) | 1984-05-22 |
FR2534254A1 (en) | 1984-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3228516B2 (en) | Naphthol derivatives and their production | |
SU584774A3 (en) | Method of preparing azoxazole derivatives | |
GB2129792A (en) | Sulpiride derived compound | |
JPH04210957A (en) | Process for preparing cyclopentene compound | |
KR0141482B1 (en) | Process for the preparation of o-carboxypyridyl and o-carboxyquinolylimidazolinones | |
EP0047674B1 (en) | Novel process for preparing isoindolin derivatives | |
SU1034605A3 (en) | Process for preparing molecular compound of beta-diethylaminoethylamide of n-chloroacetic phenoxy acid with 4-n-butyl-3,5-diketo-1,2-diphenylpyrazolidine | |
US3892802A (en) | Processes for making benzamide compounds | |
US4264500A (en) | Process of making 6-chloro-α-methyl-carbazole-2-acetic acid | |
US4731479A (en) | N-sulfamyl-3-halopropionamidines | |
US3291805A (en) | Method for the production of hydroxypicolinic acid | |
US5206388A (en) | Process for the preparation of 5,6,11,12-tetrathiotetracene | |
US3433802A (en) | 3-(n-lower-alkylanilino)pyrrolidines | |
RU2111960C1 (en) | Method of synthesis of 1-amino-1-cyanamido-2,2-dicyanethylene sodium salt | |
US4960917A (en) | Process for the preparation of an acexamic acid derivatives | |
JP3484161B2 (en) | Sulfo-N-hydroxysuccinimide and method for producing the same | |
SU1313856A1 (en) | Method for producing derivatives of cis- or trans-diaminodibenzoyl-dibenzo-18-crown-6 | |
EP0437567B1 (en) | Phenyl-glycine derivatives | |
KR920005828B1 (en) | Process for preparing salt of 2-(2-aminomethyl)-thiomethyl-5-dimethyl amino methylfuran | |
SU1490115A1 (en) | Method of producing n-acetyl-2-chloro-3-iminoindoline hydrochloride | |
KR810000454B1 (en) | Preparing process for benzoic amides | |
KR800001450B1 (en) | Process for the preparation of 1,3,5-trisubstitude benzene derivative | |
JPS60146884A (en) | Production of 1,5-benzothiazepine derivative | |
JP3538889B2 (en) | Method for producing alkylthioacetamide | |
JPS58157765A (en) | Preparation of substituted benzamide compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |